Cannabis Science, Inc.

  • Home
  • About CBIS
    • Corporate Overview
    • Leadership
      • Executive Management
      • Scientific Advisory Board
    • Corporate Responsibility
    • The Science of Cannabinoids
    • Mission Statement
    • Careers & Corporate Culture
  • R&D
    • Cannabinoid Overview
    • Programs
      • CS-TATI-1
      • CS-S/BCC-1
      • CS-NEURO-1
    • Partnering
    • R&D Approach
    • Critical Ailments
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
    • Investor Information
    • Investor Inquiry
    • CBIS Latest News
    • Analyst Report
  • Media
    • CBIS Latest News
    • CBIS News Archive
    • In The Press
  • Contact

  Mission Statement

  About Us

  Research Development

  The Science of Cannabiniods

  R&D Approach

  Critical Ailments

  Investor  Knowledge

 

  CBIS Latest News

  Leadership

What We Do

At Cannabis Science, we use an inquiring approach to discover and develop novel cannabinoid-based therapies to improve patients’ lives. From the initiation, our founders have been committed to fostering and maintaining a bold, pioneering spirit fostering the true nature of innovation from which cutting edge ideas flourish and translate into evidence-based solutions.

Read More

The Science of Cannabinoids

Cannabinoids have an extensive history dating back thousands of years, and currently there are thousands of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The endocannabinoid system possessed by all vertebrates regulates all body systems and maintains homeostasis.

Read More

CBIS Latest News

  • Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV and Kaposi Sarcoma Drug Development Program
  • Mark Wainberg, Ph.D., Joins Cannabis Science's Scientific Advisory Board; Cannabis Science Presents Further Dimensions of CS-TATI-1 Discovery Platform at 8th IAS Conference on HIV Pathogenesis
  • Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches

CBIS Twitter Feed

Tweets by @CannabisScienc1
  • Home
  • Facebook
  • Twitter
  • Google+
  • Instagram
  • LinkedIn
  • Privacy Policy
  • Contact Us

© Cannabis Science, Inc. (OTC: CBIS). All rights reserved.